0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
HPV Therapeutic Vaccines - Global Market Insights and Sales Trends 2024
Published Date: November 2023
|
Report Code: QYRE-Auto-12Y13279
Home | Market Reports | Health| Reproductive Health
Global HPV Therapeutic Vaccines Market Research Report 2023
BUY CHAPTERS

HPV Therapeutic Vaccines - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-12Y13279
Report
November 2023
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

HPV Therapeutic Vaccines - Market Size

The global HPV Therapeutic Vaccines market size is expected to reach US$ 12480 million by 2029, growing at a CAGR of 15.9% from 2023 to 2029.

HPV Therapeutic Vaccines -  Market

HPV Therapeutic Vaccines - Market

Human papilloma virus (HPV) vaccines are used to protect against HPV infections.
Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers and known as carcinogenic HPVs.
The market is mainly driven by the significant applications of HPV Therapeutic Vaccines in various end use industries. The expanding demands from the Man and Woman, are propelling HPV Therapeutic Vaccines market. Bivalent HPV vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Quadrivalent HPV vaccine segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for HPV Therapeutic Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global HPV Therapeutic Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global HPV Therapeutic Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, HPV Therapeutic Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of HPV Therapeutic Vaccines covered in this report include Merck & Co., Inc, GlaxoSmithKline plc, Shanghai Bovax Biotechnology Co., Ltd., Profectus BioSciences, Inc., 2A Pharma AB, ISA Pharmaceuticals, Pfizer, Sanofi Pasteur and Serum Institute, etc.
The global HPV Therapeutic Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck & Co., Inc
GlaxoSmithKline plc
Shanghai Bovax Biotechnology Co., Ltd.
Profectus BioSciences, Inc.
2A Pharma AB
ISA Pharmaceuticals
Pfizer
Sanofi Pasteur
Serum Institute
Emergent BioSolutions
Astellas Pharma
Johnson and Johnson.
Wantai BioPharm
INOVIO Pharmaceuticals

Scope of HPV Therapeutic Vaccines - Market Report

Report Metric Details
Report Name HPV Therapeutic Vaccines - Market
Forecasted market size in 2029 US$ 12480 million
CAGR 15.9%
Forecasted years 2023 - 2029
Global HPV Therapeutic Vaccines market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global HPV Therapeutic Vaccines market, Segment by Type:
  • Bivalent HPV vaccine
  • Quadrivalent HPV vaccine
Global HPV Therapeutic Vaccines market, by Application
  • Man
  • Woman
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter Four: Detailed analysis of HPV Therapeutic Vaccines companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
  • Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
  • Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the HPV Therapeutic Vaccines - Market size in 2029?

Ans: The HPV Therapeutic Vaccines - Market size in 2029 will be US$ 12480 million.

What are the Application segmentation covered in the HPV Therapeutic Vaccines - Market report?

Ans: The Applications covered in the HPV Therapeutic Vaccines - Market report are Man, Woman

What are the Type segmentation covered in the HPV Therapeutic Vaccines - Market report?

Ans: The Types covered in the HPV Therapeutic Vaccines - Market report are Bivalent HPV vaccine, Quadrivalent HPV vaccine

1 Market Overview of HPV Therapeutic Vaccines
1.1 HPV Therapeutic Vaccines Market Overview
1.1.1 HPV Therapeutic Vaccines Product Scope
1.1.2 HPV Therapeutic Vaccines Market Status and Outlook
1.2 Global HPV Therapeutic Vaccines Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global HPV Therapeutic Vaccines Market Size by Region (2018-2029)
1.4 Global HPV Therapeutic Vaccines Historic Market Size by Region (2018-2023)
1.5 Global HPV Therapeutic Vaccines Market Size Forecast by Region (2024-2029)
1.6 Key Regions, HPV Therapeutic Vaccines Market Size (2018-2029)
1.6.1 North America HPV Therapeutic Vaccines Market Size (2018-2029)
1.6.2 Europe HPV Therapeutic Vaccines Market Size (2018-2029)
1.6.3 Asia-Pacific HPV Therapeutic Vaccines Market Size (2018-2029)
1.6.4 Latin America HPV Therapeutic Vaccines Market Size (2018-2029)
1.6.5 Middle East & Africa HPV Therapeutic Vaccines Market Size (2018-2029)
2 HPV Therapeutic Vaccines Market by Type
2.1 Introduction
2.1.1 Bivalent HPV vaccine
2.1.2 Quadrivalent HPV vaccine
2.2 Global HPV Therapeutic Vaccines Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global HPV Therapeutic Vaccines Historic Market Size by Type (2018-2023)
2.2.2 Global HPV Therapeutic Vaccines Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America HPV Therapeutic Vaccines Revenue Breakdown by Type (2018-2029)
2.3.2 Europe HPV Therapeutic Vaccines Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific HPV Therapeutic Vaccines Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America HPV Therapeutic Vaccines Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa HPV Therapeutic Vaccines Revenue Breakdown by Type (2018-2029)
3 HPV Therapeutic Vaccines Market Overview by Application
3.1 Introduction
3.1.1 Man
3.1.2 Woman
3.2 Global HPV Therapeutic Vaccines Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global HPV Therapeutic Vaccines Historic Market Size by Application (2018-2023)
3.2.2 Global HPV Therapeutic Vaccines Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America HPV Therapeutic Vaccines Revenue Breakdown by Application (2018-2029)
3.3.2 Europe HPV Therapeutic Vaccines Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific HPV Therapeutic Vaccines Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America HPV Therapeutic Vaccines Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa HPV Therapeutic Vaccines Revenue Breakdown by Application (2018-2029)
4 HPV Therapeutic Vaccines Competition Analysis by Players
4.1 Global HPV Therapeutic Vaccines Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HPV Therapeutic Vaccines as of 2022)
4.3 Date of Key Players Enter into HPV Therapeutic Vaccines Market
4.4 Global Top Players HPV Therapeutic Vaccines Headquarters and Area Served
4.5 Key Players HPV Therapeutic Vaccines Product Solution and Service
4.6 Competitive Status
4.6.1 HPV Therapeutic Vaccines Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck & Co., Inc
5.1.1 Merck & Co., Inc Profile
5.1.2 Merck & Co., Inc Main Business
5.1.3 Merck & Co., Inc HPV Therapeutic Vaccines Products, Services and Solutions
5.1.4 Merck & Co., Inc HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.1.5 Merck & Co., Inc Recent Developments
5.2 GlaxoSmithKline plc
5.2.1 GlaxoSmithKline plc Profile
5.2.2 GlaxoSmithKline plc Main Business
5.2.3 GlaxoSmithKline plc HPV Therapeutic Vaccines Products, Services and Solutions
5.2.4 GlaxoSmithKline plc HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.2.5 GlaxoSmithKline plc Recent Developments
5.3 Shanghai Bovax Biotechnology Co., Ltd.
5.3.1 Shanghai Bovax Biotechnology Co., Ltd. Profile
5.3.2 Shanghai Bovax Biotechnology Co., Ltd. Main Business
5.3.3 Shanghai Bovax Biotechnology Co., Ltd. HPV Therapeutic Vaccines Products, Services and Solutions
5.3.4 Shanghai Bovax Biotechnology Co., Ltd. HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.3.5 Profectus BioSciences, Inc. Recent Developments
5.4 Profectus BioSciences, Inc.
5.4.1 Profectus BioSciences, Inc. Profile
5.4.2 Profectus BioSciences, Inc. Main Business
5.4.3 Profectus BioSciences, Inc. HPV Therapeutic Vaccines Products, Services and Solutions
5.4.4 Profectus BioSciences, Inc. HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.4.5 Profectus BioSciences, Inc. Recent Developments
5.5 2A Pharma AB
5.5.1 2A Pharma AB Profile
5.5.2 2A Pharma AB Main Business
5.5.3 2A Pharma AB HPV Therapeutic Vaccines Products, Services and Solutions
5.5.4 2A Pharma AB HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.5.5 2A Pharma AB Recent Developments
5.6 ISA Pharmaceuticals
5.6.1 ISA Pharmaceuticals Profile
5.6.2 ISA Pharmaceuticals Main Business
5.6.3 ISA Pharmaceuticals HPV Therapeutic Vaccines Products, Services and Solutions
5.6.4 ISA Pharmaceuticals HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.6.5 ISA Pharmaceuticals Recent Developments
5.7 Pfizer
5.7.1 Pfizer Profile
5.7.2 Pfizer Main Business
5.7.3 Pfizer HPV Therapeutic Vaccines Products, Services and Solutions
5.7.4 Pfizer HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.7.5 Pfizer Recent Developments
5.8 Sanofi Pasteur
5.8.1 Sanofi Pasteur Profile
5.8.2 Sanofi Pasteur Main Business
5.8.3 Sanofi Pasteur HPV Therapeutic Vaccines Products, Services and Solutions
5.8.4 Sanofi Pasteur HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.8.5 Sanofi Pasteur Recent Developments
5.9 Serum Institute
5.9.1 Serum Institute Profile
5.9.2 Serum Institute Main Business
5.9.3 Serum Institute HPV Therapeutic Vaccines Products, Services and Solutions
5.9.4 Serum Institute HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.9.5 Serum Institute Recent Developments
5.10 Emergent BioSolutions
5.10.1 Emergent BioSolutions Profile
5.10.2 Emergent BioSolutions Main Business
5.10.3 Emergent BioSolutions HPV Therapeutic Vaccines Products, Services and Solutions
5.10.4 Emergent BioSolutions HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.10.5 Emergent BioSolutions Recent Developments
5.11 Astellas Pharma
5.11.1 Astellas Pharma Profile
5.11.2 Astellas Pharma Main Business
5.11.3 Astellas Pharma HPV Therapeutic Vaccines Products, Services and Solutions
5.11.4 Astellas Pharma HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.11.5 Astellas Pharma Recent Developments
5.12 Johnson and Johnson.
5.12.1 Johnson and Johnson. Profile
5.12.2 Johnson and Johnson. Main Business
5.12.3 Johnson and Johnson. HPV Therapeutic Vaccines Products, Services and Solutions
5.12.4 Johnson and Johnson. HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.12.5 Johnson and Johnson. Recent Developments
5.13 Wantai BioPharm
5.13.1 Wantai BioPharm Profile
5.13.2 Wantai BioPharm Main Business
5.13.3 Wantai BioPharm HPV Therapeutic Vaccines Products, Services and Solutions
5.13.4 Wantai BioPharm HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.13.5 Wantai BioPharm Recent Developments
5.14 INOVIO Pharmaceuticals
5.14.1 INOVIO Pharmaceuticals Profile
5.14.2 INOVIO Pharmaceuticals Main Business
5.14.3 INOVIO Pharmaceuticals HPV Therapeutic Vaccines Products, Services and Solutions
5.14.4 INOVIO Pharmaceuticals HPV Therapeutic Vaccines Revenue (US$ Million) & (2018-2023)
5.14.5 INOVIO Pharmaceuticals Recent Developments
6 North America
6.1 North America HPV Therapeutic Vaccines Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe HPV Therapeutic Vaccines Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific HPV Therapeutic Vaccines Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America HPV Therapeutic Vaccines Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa HPV Therapeutic Vaccines Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 HPV Therapeutic Vaccines Market Dynamics
11.1 HPV Therapeutic Vaccines Industry Trends
11.2 HPV Therapeutic Vaccines Market Drivers
11.3 HPV Therapeutic Vaccines Market Challenges
11.4 HPV Therapeutic Vaccines Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables
    Table 1. Global Market HPV Therapeutic Vaccines Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
    Table 2. Global HPV Therapeutic Vaccines Market Size by Region (2018-2023) & (US$ Million)
    Table 3. Global HPV Therapeutic Vaccines Market Size Share by Region (2018-2023)
    Table 4. Global HPV Therapeutic Vaccines Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 5. Global HPV Therapeutic Vaccines Forecasted Market Size Share by Region (2024-2029)
    Table 6. Global HPV Therapeutic Vaccines Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
    Table 7. Global HPV Therapeutic Vaccines Market Size by Type (2018-2023) & (US$ Million)
    Table 8. Global HPV Therapeutic Vaccines Revenue Market Share by Type (2018-2023)
    Table 9. Global HPV Therapeutic Vaccines Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 10. Global HPV Therapeutic Vaccines Revenue Market Share by Type (2024-2029)
    Table 11. North America HPV Therapeutic Vaccines Revenue by Type (2018-2023) & (US$ Million)
    Table 12. North America HPV Therapeutic Vaccines Revenue by Type (2024-2029) & (US$ Million)
    Table 13. Europe HPV Therapeutic Vaccines Revenue by Type (2018-2023) & (US$ Million)
    Table 14. Europe HPV Therapeutic Vaccines Revenue by Type (2024-2029) & (US$ Million)
    Table 15. Asia-Pacific HPV Therapeutic Vaccines Revenue by Type (2018-2023) & (US$ Million)
    Table 16. Asia-Pacific HPV Therapeutic Vaccines Revenue by Type (2024-2029) & (US$ Million)
    Table 17. Latin America HPV Therapeutic Vaccines Revenue by Type (2018-2023) & (US$ Million)
    Table 18. Latin America HPV Therapeutic Vaccines Revenue by Type (2024-2029) & (US$ Million)
    Table 19. Middle East and Africa HPV Therapeutic Vaccines Revenue by Type (2018-2023) & (US$ Million)
    Table 20. Middle East and Africa HPV Therapeutic Vaccines Revenue by Type (2024-2029) & (US$ Million)
    Table 21. Global HPV Therapeutic Vaccines Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
    Table 22. Global HPV Therapeutic Vaccines Market Size by Application (2018-2023) & (US$ Million)
    Table 23. Global HPV Therapeutic Vaccines Revenue Market Share by Application (2018-2023)
    Table 24. Global HPV Therapeutic Vaccines Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 25. Global HPV Therapeutic Vaccines Revenue Market Share by Application (2024-2029)
    Table 26. North America HPV Therapeutic Vaccines Revenue by Application (2018-2023) & (US$ Million)
    Table 27. North America HPV Therapeutic Vaccines Revenue by Application (2024-2029) & (US$ Million)
    Table 28. Europe HPV Therapeutic Vaccines Revenue by Application (2018-2023) & (US$ Million)
    Table 29. Europe HPV Therapeutic Vaccines Revenue by Application (2024-2029) & (US$ Million)
    Table 30. Asia-Pacific HPV Therapeutic Vaccines Revenue by Application (2018-2023) & (US$ Million)
    Table 31. Asia-Pacific HPV Therapeutic Vaccines Revenue by Application (2024-2029) & (US$ Million)
    Table 32. Latin America HPV Therapeutic Vaccines Revenue by Application (2018-2023) & (US$ Million)
    Table 33. Latin America HPV Therapeutic Vaccines Revenue by Application (2024-2029) & (US$ Million)
    Table 34. Middle East and Africa HPV Therapeutic Vaccines Revenue by Application (2018-2023) & (US$ Million)
    Table 35. Middle East and Africa HPV Therapeutic Vaccines Revenue by Application (2024-2029) & (US$ Million)
    Table 36. Global HPV Therapeutic Vaccines Revenue (US$ Million) by Players (2018-2023)
    Table 37. Global HPV Therapeutic Vaccines Revenue Market Share by Players (2018-2023)
    Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HPV Therapeutic Vaccines as of 2022)
    Table 39. Date of Key Players Enter into HPV Therapeutic Vaccines Market
    Table 40. Global HPV Therapeutic Vaccines Key Players Headquarters and Area Served
    Table 41. HPV Therapeutic Vaccines Product Solution and Service
    Table 42. Global HPV Therapeutic Vaccines Players Market Concentration Ratio (CR5 and HHI)
    Table 43. Mergers & Acquisitions, Expansion Plans
    Table 44. Merck & Co., Inc Basic Information List
    Table 45. Merck & Co., Inc Description and Business Overview
    Table 46. Merck & Co., Inc HPV Therapeutic Vaccines Products, Services and Solutions
    Table 47. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of Merck & Co., Inc (2018-2023)
    Table 48. Merck & Co., Inc Recent Developments
    Table 49. GlaxoSmithKline plc Basic Information List
    Table 50. GlaxoSmithKline plc Description and Business Overview
    Table 51. GlaxoSmithKline plc HPV Therapeutic Vaccines Products, Services and Solutions
    Table 52. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of GlaxoSmithKline plc (2018-2023)
    Table 53. GlaxoSmithKline plc Recent Developments
    Table 54. Shanghai Bovax Biotechnology Co., Ltd. Basic Information List
    Table 55. Shanghai Bovax Biotechnology Co., Ltd. Description and Business Overview
    Table 56. Shanghai Bovax Biotechnology Co., Ltd. HPV Therapeutic Vaccines Products, Services and Solutions
    Table 57. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of Shanghai Bovax Biotechnology Co., Ltd. (2018-2023)
    Table 58. Shanghai Bovax Biotechnology Co., Ltd. Recent Developments
    Table 59. Profectus BioSciences, Inc. Basic Information List
    Table 60. Profectus BioSciences, Inc. Description and Business Overview
    Table 61. Profectus BioSciences, Inc. HPV Therapeutic Vaccines Products, Services and Solutions
    Table 62. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of Profectus BioSciences, Inc. (2018-2023)
    Table 63. Profectus BioSciences, Inc. Recent Developments
    Table 64. 2A Pharma AB Basic Information List
    Table 65. 2A Pharma AB Description and Business Overview
    Table 66. 2A Pharma AB HPV Therapeutic Vaccines Products, Services and Solutions
    Table 67. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of 2A Pharma AB (2018-2023)
    Table 68. 2A Pharma AB Recent Developments
    Table 69. ISA Pharmaceuticals Basic Information List
    Table 70. ISA Pharmaceuticals Description and Business Overview
    Table 71. ISA Pharmaceuticals HPV Therapeutic Vaccines Products, Services and Solutions
    Table 72. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of ISA Pharmaceuticals (2018-2023)
    Table 73. ISA Pharmaceuticals Recent Developments
    Table 74. Pfizer Basic Information List
    Table 75. Pfizer Description and Business Overview
    Table 76. Pfizer HPV Therapeutic Vaccines Products, Services and Solutions
    Table 77. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of Pfizer (2018-2023)
    Table 78. Pfizer Recent Developments
    Table 79. Sanofi Pasteur Basic Information List
    Table 80. Sanofi Pasteur Description and Business Overview
    Table 81. Sanofi Pasteur HPV Therapeutic Vaccines Products, Services and Solutions
    Table 82. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of Sanofi Pasteur (2018-2023)
    Table 83. Sanofi Pasteur Recent Developments
    Table 84. Serum Institute Basic Information List
    Table 85. Serum Institute Description and Business Overview
    Table 86. Serum Institute HPV Therapeutic Vaccines Products, Services and Solutions
    Table 87. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of Serum Institute (2018-2023)
    Table 88. Serum Institute Recent Developments
    Table 89. Emergent BioSolutions Basic Information List
    Table 90. Emergent BioSolutions Description and Business Overview
    Table 91. Emergent BioSolutions HPV Therapeutic Vaccines Products, Services and Solutions
    Table 92. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of Emergent BioSolutions (2018-2023)
    Table 93. Emergent BioSolutions Recent Developments
    Table 94. Astellas Pharma Basic Information List
    Table 95. Astellas Pharma Description and Business Overview
    Table 96. Astellas Pharma HPV Therapeutic Vaccines Products, Services and Solutions
    Table 97. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of Astellas Pharma (2018-2023)
    Table 98. Astellas Pharma Recent Developments
    Table 99. Johnson and Johnson. Basic Information List
    Table 100. Johnson and Johnson. Description and Business Overview
    Table 101. Johnson and Johnson. HPV Therapeutic Vaccines Products, Services and Solutions
    Table 102. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of Johnson and Johnson. (2018-2023)
    Table 103. Johnson and Johnson. Recent Developments
    Table 104. Wantai BioPharm Basic Information List
    Table 105. Wantai BioPharm Description and Business Overview
    Table 106. Wantai BioPharm HPV Therapeutic Vaccines Products, Services and Solutions
    Table 107. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of Wantai BioPharm (2018-2023)
    Table 108. Wantai BioPharm Recent Developments
    Table 109. INOVIO Pharmaceuticals Basic Information List
    Table 110. INOVIO Pharmaceuticals Description and Business Overview
    Table 111. INOVIO Pharmaceuticals HPV Therapeutic Vaccines Products, Services and Solutions
    Table 112. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of INOVIO Pharmaceuticals (2018-2023)
    Table 113. INOVIO Pharmaceuticals Recent Developments
    Table 114. North America HPV Therapeutic Vaccines Market Size by Country (2018-2023) & (US$ Million)
    Table 115. North America HPV Therapeutic Vaccines Market Size by Country (2024-2029) & (US$ Million)
    Table 116. Europe HPV Therapeutic Vaccines Market Size by Country (2018-2023) & (US$ Million)
    Table 117. Europe HPV Therapeutic Vaccines Market Size by Country (2024-2029) & (US$ Million)
    Table 118. Asia-Pacific HPV Therapeutic Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 119. Asia-Pacific HPV Therapeutic Vaccines Market Size by Region (2018-2023) & (US$ Million)
    Table 120. Asia-Pacific HPV Therapeutic Vaccines Market Size by Region (2024-2029) & (US$ Million)
    Table 121. Asia-Pacific HPV Therapeutic Vaccines Market Share by Region (2018-2023)
    Table 122. Asia-Pacific HPV Therapeutic Vaccines Market Share by Region (2024-2029)
    Table 123. Latin America HPV Therapeutic Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 124. Latin America HPV Therapeutic Vaccines Market Size by Country (2018-2023) & (US$ Million)
    Table 125. Latin America HPV Therapeutic Vaccines Market Size by Country (2024-2029) & (US$ Million)
    Table 126. Middle East & Africa HPV Therapeutic Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 127. Middle East & Africa HPV Therapeutic Vaccines Market Size by Country (2018-2023) & (US$ Million)
    Table 128. Middle East & Africa HPV Therapeutic Vaccines Market Size by Country (2024-2029) & (US$ Million)
    Table 129. HPV Therapeutic Vaccines Market Trends
    Table 130. HPV Therapeutic Vaccines Market Drivers
    Table 131. HPV Therapeutic Vaccines Market Challenges
    Table 132. HPV Therapeutic Vaccines Market Restraints
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global HPV Therapeutic Vaccines Market Size Year-over-Year 2018-2029 & (US$ Million)
    Figure 2. Global HPV Therapeutic Vaccines Market Size (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global HPV Therapeutic Vaccines Market Share by Regions: 2022 VS 2029
    Figure 4. Global HPV Therapeutic Vaccines Forecasted Market Size Share by Region (2024-2029)
    Figure 5. North America HPV Therapeutic Vaccines Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 6. Europe HPV Therapeutic Vaccines Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 7. Asia-Pacific HPV Therapeutic Vaccines Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 8. Latin America HPV Therapeutic Vaccines Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 9. Middle East & Africa HPV Therapeutic Vaccines Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 10. Product Picture of Bivalent HPV vaccine
    Figure 11. Global Bivalent HPV vaccine Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 12. Product Picture of Quadrivalent HPV vaccine
    Figure 13. Global Quadrivalent HPV vaccine Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 14. Global HPV Therapeutic Vaccines Market Size Share by Type: 2022 & 2029
    Figure 15. North America HPV Therapeutic Vaccines Revenue Market Share by Type (2018-2029)
    Figure 16. Europe HPV Therapeutic Vaccines Revenue Market Share by Type (2018-2029)
    Figure 17. Asia-Pacific HPV Therapeutic Vaccines Revenue Market Share by Type (2018-2029)
    Figure 18. Latin America HPV Therapeutic Vaccines Revenue Market Share by Type (2018-2029)
    Figure 19. Middle East and Africa HPV Therapeutic Vaccines Revenue Market Share by Type (2018-2029)
    Figure 20. Man Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 21. Woman Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 22. Global HPV Therapeutic Vaccines Market Size Share by Application: 2022 & 2029
    Figure 23. North America HPV Therapeutic Vaccines Revenue Market Share by Application (2018-2029)
    Figure 24. Europe HPV Therapeutic Vaccines Revenue Market Share by Application (2018-2029)
    Figure 25. Asia-Pacific HPV Therapeutic Vaccines Revenue Market Share by Application (2018-2029)
    Figure 26. Latin America HPV Therapeutic Vaccines Revenue Market Share by Application (2018-2029)
    Figure 27. Middle East and Africa HPV Therapeutic Vaccines Revenue Market Share by Application (2018-2029)
    Figure 28. HPV Therapeutic Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 29. Global Top 5 and Top 10 Players HPV Therapeutic Vaccines Market Share in 2022
    Figure 30. North America HPV Therapeutic Vaccines Market Share by Country (2018-2029)
    Figure 31. U.S. HPV Therapeutic Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 32. Canada HPV Therapeutic Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 33. Germany HPV Therapeutic Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 34. France HPV Therapeutic Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 35. U.K. HPV Therapeutic Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 36. Italy HPV Therapeutic Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 37. Russia HPV Therapeutic Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 38. Nordic Countries HPV Therapeutic Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 39. Asia-Pacific HPV Therapeutic Vaccines Market Share by Region (2018-2029)
    Figure 40. China HPV Therapeutic Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 41. Japan HPV Therapeutic Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 42. South Korea HPV Therapeutic Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 43. Southeast Asia HPV Therapeutic Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 44. India HPV Therapeutic Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 45. Australia HPV Therapeutic Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 46. Latin America HPV Therapeutic Vaccines Market Share by Country (2018-2029)
    Figure 47. Mexico HPV Therapeutic Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 48. Brazil HPV Therapeutic Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 49. Middle East & Africa HPV Therapeutic Vaccines Market Share by Country (2018-2029)
    Figure 50. Turkey HPV Therapeutic Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 51. Saudi Arabia HPV Therapeutic Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 52. UAE HPV Therapeutic Vaccines Market Size (2018-2029) & (US$ Million)
    Figure 53. Bottom-up and Top-down Approaches for This Report
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS